β-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes

Journal of Neuroscience Research

Volumn 47, Issue 2, 1997, Pages 216-223

  Salinero, O ^a   Moreno Flores, M T ^a   Ceballos, M L ^b   Wandosell, F ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Alzheimer's disease; cytoskeletal proteins; glial response

Indexed keywords

AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN; MESSENGER RNA; VIMENTIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CYTOSKELETON; IMMUNOCYTOCHEMISTRY; INTERMEDIATE FILAMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RNA ANALYSIS;

AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; CELLS, CULTURED; CEREBRAL CORTEX; CYTOSKELETON; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; PEPTIDE FRAGMENTS; RATS; RNA, MESSENGER;

EID: 0031018428     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970115)47:2<216::AID-JNR10>3.0.CO;2-0     Document Type: Article

References (46)

1. Araujo M, Cotman CW (1992): β-Amyloid stimulate glial cells to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 569:141-145.
2. Araujo M, Wandosell F (1996): Differential cellular response after glutamate analog hippocampal damage. J Neurosci Res, 44: 397-409.
3. Behl C, Davis JB, Cole GM, Schubert D (1992): Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Commun 186:944-952.
4. Behl C, Davis JB, Lesley R, Schubert D (1994): Hydrogen peroxide mediates Amyloid β protein toxicity. Cell 77:817-827.
5. Bignami A, Dahl D, Rueger DC (1980): Glial fibrillary acidic (GFA) protein in normal neural cells and in pathological conditions. In Federoff S, Herts L (eds): "Advances in Cellular Neurobiology." New York: Academic, Vol. 1, pp. 285-310.
6. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA (1993): Generation of β-Amyloid in the secretoty pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 90:2092-2096.
7. Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995): β-Amyloid fibrils induce tau phosphorylation and loss microtubule binding. Neuron 14-4:879-888.
8. Canning DR, McKeon RJ, DeWhitt DA, Perry G, Wujeck J, Frederickson R, Silver J (1993): β-Amyloid of Alzheimer disease's induce reactive gliosis that inhibits axonal outgrowth. Exp Neurol 124-2:289-298.
9. Cavanaugh KP, Gurwitz D, Cunningham DD, Bradshaw R (1990): Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 54-5:1735-1743.
10. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by guanidium thiocyanate-phenocloroform extraction. Anal Biochem 16-2:156-159.
11. Cummings BJ, Su JH, Cotman CW (1993): Neuritic involvement within bFGF immunopositive plaque of Alzheimer's disease. Exp Neurol 124:315-325.
12. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG (1988): p1B15: a cDNA clone of the rat mRNA engoding cyclophilin. DNA 7-4:261-267.
13. Dickinson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SC (1988): A double-labelling immunohistochemical study of senile plaques. Am J Pathol 32:86-101.
14. Duffy PE, Rapport M, Graf L (1990): Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 30:778-782.
15. Emre M, Guela C, Ransil BJ, Mesulan M-M (1992): The acute neurotoxicity and effects of intracerebrally injected β amyloid in rat brain. Neurobiol Aging 13:553-559.
16. Eng LF (1988): Regulation of glial intermediate filaments in astrogliosis. In "The Biochemical Pathology of Astrocytes." New York: Alan R. Liss, pp. 79-91.
17. Eng LF, Ghimikar RS (1994): GFAP and astrogliosis. Brain Pathol 4-(3):229-237.
18. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ (1990): Cleavage of amyloid beta-peptide during constitutive processing of its precursor. Science 248:1122-1124.
19. Federoff S, McAuley WA, Houle JD, Devon RM (1984): Astrocyte cell lineage: V Similarity of astrocytes that form in the presence of dBcAMP in cultures to reactive astrocytes in vivo. J Neurosci Res 12:15-27.
20. Geistert EE, Johnson HG, Binder LI (1990): Expression of microtubule associated protein 2 by reactive astrocytes. Proc Natl Acad Sci USA 87:3967-3971.
21. Glenner GG (1988): Alzheimer's disease: Its proteins and genes. Cell 52:307-308.
22. Glenner GG, Wong CW (1984): Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
23. Golde TE, Estus S, Youkin LH, Selkoe DJ, Youkin SG (1992): Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728-730.
24. Gomez-Pinilla F, Lee JK, Cotman CW (1992): Basic FGF in adult rat brain: Cellular distribution and response to entorinal lesion and fimbria-fornix transection. J Neurosci 12:345-355.
25. Haas CA, Koo EH, Mellon A, Hung AY, Selkoe DJ (1992): Targeting of cell surface β-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 357:500-503.
26. Haas CA, Selkoe DJ (1993): Cellular processing of β-Amyloid precursor protein and the genesis of Amyloid β-peptide. Cell 75: 1039-1042.
27. Harlow E, Lane D (1988): "Antibodies: A Laboratory Manual." Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
28. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Liu W, Shafit-Zargado B, Aquino DA, Zhao M, Dickinson DW, Brosnan CF, Lee SC (1994): Cytoskeletal alterations in human fetal astrocytes induced by interleukin 1β. J Neurochem 63-5: 1625-1634.
30. Mandybur I, Chuirazzi CC (1990): Astrocytes and the plaques of Alzheimer's disease. Neurology 40:635-639.
31. Mattson MP, Cheng B, Davis D, Bryant K, Leieburg I, Rydel R (1992): β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
32. Mattson MP, Cheng B, Culwell AR, Esch FS, Leieburg I, Rydel R (1993): Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid-precursor protein. Neuron 10:243-254.
33. McCarthy KD, de Vellis J (1980): Preparation of separed astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
34. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991): Apolipoprotein E immunoreactivity in cerebral deposits and neurofilaments tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 54-1:163-166.
35. Peña LA, Brecher CW, Marshak D (1995): β-amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures. Mol Brain Res 34:118-126.
36. Pike C, Cummings BJ, Cotman CW (1992): β-Amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimrer pathology. Neuroreport 3:769-772.
37. Pike CJ, Cummings BJ, Monzavi R, Cotman CW (1994): β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63-2:517-531.
38. Selkoe DJ (1991): The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
39. Shearman MS, Hawtin SR, Tailor VJ (1995): The intracellular component of cellular 3-(4-5-dimathylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J Neurochem 65-1:218-227.
40. Shoji M, Golde T, Ghiso J, Cheung T, Estus S, Shaffer L, Cai X, McKay D, Tinter R, Frangione B, Toukin S (1992): Production of the Alzheimer βprotein by normal proteolytic processing. Science 258:126-129.
41. Siman R, Card JP, Nelson RB, Davis LG (1989): Expression of β-Amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3:275-285.
42. Wandosell F, Bovolenta P, Nieto-Sampedro M (1993): Differences between reactive astrocytes and cultured astrocytes treated with di-butyryl-cyclic AMP. J Neuropathol Exp Neurol 52-3:202-215.
43. Wang R, Meschia JF, Cotter RJ, Sisodia SS (1991): Secretion of βA4 amyloid precursor protein. Identification of a clevage site in mammalian cells. J Biol Chem 266:16960-16964.
44. Weiss J, Pike CJ, Cotman CW (1994): Ca+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J Neurochem 62-1:372-375.
45. Yankner B, Dawes L, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve R (1989): Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245: 417-420.
46. Yankner BA, Dufy LK, Kirschner DA (1990): Neurotrophic effects of β-Amyloid protein: Reversal by tachykinin neuropeptides. Science 250:279-282.